Nook Therapeutics to hyperactivate ‘the brains of the immune machine’ with $54M release
Corner Therapeutics’ $54 million Series A will probably be used to deliver new immunotherapies for cancer and infectious diseases into the clinic, the compabig apple mentioned Thursday. The beginningup is led by